Champions Oncology, Inc.

CSBR Stock Healthcare Biotechnology
$4.93
-0.09 (-1.79%)
Price as of Aug 28, 2026 market close

Performance

1 Month
-6.3%
3 Months
-15.5%
YTD
-28.7%
1 Year
-25.3%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
59.9%
Largest decline max drawdown, since Aug 2025
-40.7%
Risk-adjusted return Sharpe ratio, 1-year
-0.19

Own CSBR?

See how CSBR contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.